This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Peregrine Pharmaceuticals Inc (PPHM)

NASDAQ: Health Care

Company Income Statement
Apr 2014 Apr 2013 Apr 2012 Apr 2011
Sales 22.40M 21.68M 15.23M 13.49M
Cost of Sales 12.12M 11.51M 9.21M 5.45M
Gross Operating Profit 10.28M 10.18M 6.02M 8.04M
Selling, General, and Administrative Expenses 17.27M 13.13M 11.46M 11.42M
Research & Development 27.72M 24.31M 35.69M 29.46M
Operating Income before D & A (EBITDA) -34.72M -27.26M -41.13M -32.84M
Depreciation & Amortization 986.00K 1.09M 941.00K 1.84M
Interest Income 349.00K 322.00K 41.00K 1.05M
Other Income - Net 0.00 -1.70M 0.00 0.00
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -35.36M -29.73M -42.03M -33.64M
Interest Expense 5.00K 54.00K 90.00K 516.00K
Pre-Tax Income -35.36M -29.78M -42.12M -34.15M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -35.36M -29.78M -42.12M -34.15M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -35.36M -29.78M -42.12M -34.15M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -35.36M -29.78M -42.12M -34.15M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-35.36M -29.78M -42.12M -34.15M
Preferred Dividends
Net Income Available To Common -35.76M -29.78M -42.12M -34.15M
Basic EPS from Continuing Ops. -0.22 -0.25 -0.50 -0.56
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.22 -0.25 -0.50 -0.56
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.22 -0.25 -0.50 -0.56
Basic Normalized Net Income/Share -0.22 -0.25 -0.50 -0.56
EPS fr Continuing Ops. -0.22 -0.25 -0.50 -0.56
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.22 -0.25 -0.50 -0.56
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.22 -0.25 -0.50 -0.56
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.22 -0.25 -0.50 -0.56
Dividends Paid per Share 0.00 0.00 0.00 0.00
PPHM News

PPHM Peregrine Pharmaceuticals Inc

Analysts Ratings for PPHM

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET PPHM ANALYST REPORT

Brokerage Partners

PPHM Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs